Cargando…

Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer

The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behaviour and response to therapy translates into an urgent need for robust molecular disease subclassifiers that can explain this heterogeneity beyond current parameters (MSI, KRAS, BRAF). Attempts to fill...

Descripción completa

Detalles Bibliográficos
Autores principales: Budinska, Eva, Popovici, Vlad, Tejpar, Sabine, D'Ario, Giovanni, Lapique, Nicolas, Sikora, Katarzyna Otylia, Di Narzo, Antonio Fabio, Yan, Pu, Hodgson, John Graeme, Weinrich, Scott, Bosman, Fred, Roth, Arnaud, Delorenzi, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840702/
https://www.ncbi.nlm.nih.gov/pubmed/23836465
http://dx.doi.org/10.1002/path.4212
_version_ 1782478554906230784
author Budinska, Eva
Popovici, Vlad
Tejpar, Sabine
D'Ario, Giovanni
Lapique, Nicolas
Sikora, Katarzyna Otylia
Di Narzo, Antonio Fabio
Yan, Pu
Hodgson, John Graeme
Weinrich, Scott
Bosman, Fred
Roth, Arnaud
Delorenzi, Mauro
author_facet Budinska, Eva
Popovici, Vlad
Tejpar, Sabine
D'Ario, Giovanni
Lapique, Nicolas
Sikora, Katarzyna Otylia
Di Narzo, Antonio Fabio
Yan, Pu
Hodgson, John Graeme
Weinrich, Scott
Bosman, Fred
Roth, Arnaud
Delorenzi, Mauro
author_sort Budinska, Eva
collection PubMed
description The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behaviour and response to therapy translates into an urgent need for robust molecular disease subclassifiers that can explain this heterogeneity beyond current parameters (MSI, KRAS, BRAF). Attempts to fill this gap are emerging. The Cancer Genome Atlas (TGCA) reported two main CRC groups, based on the incidence and spectrum of mutated genes, and another paper reported an EMT expression signature defined subgroup. We performed a prior free analysis of CRC heterogeneity on 1113 CRC gene expression profiles and confronted our findings to established molecular determinants and clinical, histopathological and survival data. Unsupervised clustering based on gene modules allowed us to distinguish at least five different gene expression CRC subtypes, which we call surface crypt-like, lower crypt-like, CIMP-H-like, mesenchymal and mixed. A gene set enrichment analysis combined with literature search of gene module members identified distinct biological motifs in different subtypes. The subtypes, which were not derived based on outcome, nonetheless showed differences in prognosis. Known gene copy number variations and mutations in key cancer-associated genes differed between subtypes, but the subtypes provided molecular information beyond that contained in these variables. Morphological features significantly differed between subtypes. The objective existence of the subtypes and their clinical and molecular characteristics were validated in an independent set of 720 CRC expression profiles. Our subtypes provide a novel perspective on the heterogeneity of CRC. The proposed subtypes should be further explored retrospectively on existing clinical trial datasets and, when sufficiently robust, be prospectively assessed for clinical relevance in terms of prognosis and treatment response predictive capacity. Original microarray data were uploaded to the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) under Accession Nos E-MTAB-990 and E-MTAB-1026.
format Online
Article
Text
id pubmed-3840702
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-38407022013-12-02 Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer Budinska, Eva Popovici, Vlad Tejpar, Sabine D'Ario, Giovanni Lapique, Nicolas Sikora, Katarzyna Otylia Di Narzo, Antonio Fabio Yan, Pu Hodgson, John Graeme Weinrich, Scott Bosman, Fred Roth, Arnaud Delorenzi, Mauro J Pathol Original Papers The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behaviour and response to therapy translates into an urgent need for robust molecular disease subclassifiers that can explain this heterogeneity beyond current parameters (MSI, KRAS, BRAF). Attempts to fill this gap are emerging. The Cancer Genome Atlas (TGCA) reported two main CRC groups, based on the incidence and spectrum of mutated genes, and another paper reported an EMT expression signature defined subgroup. We performed a prior free analysis of CRC heterogeneity on 1113 CRC gene expression profiles and confronted our findings to established molecular determinants and clinical, histopathological and survival data. Unsupervised clustering based on gene modules allowed us to distinguish at least five different gene expression CRC subtypes, which we call surface crypt-like, lower crypt-like, CIMP-H-like, mesenchymal and mixed. A gene set enrichment analysis combined with literature search of gene module members identified distinct biological motifs in different subtypes. The subtypes, which were not derived based on outcome, nonetheless showed differences in prognosis. Known gene copy number variations and mutations in key cancer-associated genes differed between subtypes, but the subtypes provided molecular information beyond that contained in these variables. Morphological features significantly differed between subtypes. The objective existence of the subtypes and their clinical and molecular characteristics were validated in an independent set of 720 CRC expression profiles. Our subtypes provide a novel perspective on the heterogeneity of CRC. The proposed subtypes should be further explored retrospectively on existing clinical trial datasets and, when sufficiently robust, be prospectively assessed for clinical relevance in terms of prognosis and treatment response predictive capacity. Original microarray data were uploaded to the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) under Accession Nos E-MTAB-990 and E-MTAB-1026. John Wiley & Sons, Ltd 2013-09 2013-07-08 /pmc/articles/PMC3840702/ /pubmed/23836465 http://dx.doi.org/10.1002/path.4212 Text en Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Original Papers
Budinska, Eva
Popovici, Vlad
Tejpar, Sabine
D'Ario, Giovanni
Lapique, Nicolas
Sikora, Katarzyna Otylia
Di Narzo, Antonio Fabio
Yan, Pu
Hodgson, John Graeme
Weinrich, Scott
Bosman, Fred
Roth, Arnaud
Delorenzi, Mauro
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
title Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
title_full Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
title_fullStr Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
title_full_unstemmed Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
title_short Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
title_sort gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840702/
https://www.ncbi.nlm.nih.gov/pubmed/23836465
http://dx.doi.org/10.1002/path.4212
work_keys_str_mv AT budinskaeva geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT popovicivlad geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT tejparsabine geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT dariogiovanni geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT lapiquenicolas geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT sikorakatarzynaotylia geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT dinarzoantoniofabio geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT yanpu geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT hodgsonjohngraeme geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT weinrichscott geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT bosmanfred geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT rotharnaud geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer
AT delorenzimauro geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer